...
首页> 外文期刊>Materials science & engineering >Versatile quarto stimuli nanostructure based on Trojan Horse approach for cancer therapy: Synthesis, characterization, in vitro and in vivo studies
【24h】

Versatile quarto stimuli nanostructure based on Trojan Horse approach for cancer therapy: Synthesis, characterization, in vitro and in vivo studies

机译:基于Trojan Horse方法的多功能quato刺激纳米结构,用于癌症治疗:合成,表征,体外和体内研究

获取原文
获取原文并翻译 | 示例

摘要

Nanostructured delivery and diagnostic systems that induces specific targeting properties by exploiting the local physicochemical tumour characteristics will be evaluated is the present work. It is well known that cancer cells have specific physicochemical characteristics, which can be taken into consideration for the design of a broad spectrum of drug delivery systems (DDS). Some of those characteristics including the different temperature environment their susceptibility when temperature ranges between 40 and 43 ℃ where cell apoptosis is induced, the intra- and extra-cellular pH which varies from 6.0 to 6.8, for cancer cells, and 6.5 to 7.4 for normal cells respectively, (lysosomes acidic pH ranges 4-5). Additional significant factors are the overexpressed receptors on the tumour surface. Loading and release studies were carried out by using the anthracycline drug Doxorubicin and their cytotoxicity was evaluated by using the MTT assay in healthy and diseased cell lines. The highlight of this work is the in vitro and in vivo studies which were performed in order to evaluate different nanostructures as for their biodistribution, pharmacokinetic and toxicity per se.
机译:通过开发局部理化肿瘤特征诱导特异性靶向特性的纳米结构传递和诊断系统将是目前的工作。众所周知,癌细胞具有特定的理化特性,在设计广泛的药物递送系统(DDS)时可以考虑这些特性。其中一些特征包括不同的温度环境,当温度在40到43℃之间时会诱发细胞凋亡,癌细胞的细胞内和细胞外pH值从6.0到6.8,正常细胞的pH值从6.5到7.4不等。细胞分别(溶酶体酸性pH范围4-5)。其他重要因素是肿瘤表面上过表达的受体。使用蒽环类药物阿霉素进行负载和释放研究,并通过MTT分析评估健康和患病细胞系的细胞毒性。这项工作的重点是进行体外和体内研究,以评估不同的纳米结构的生物分布,药代动力学和毒性本身。

著录项

  • 来源
    《Materials science & engineering 》 |2017年第10期| 605-612| 共8页
  • 作者单位

    Institute for Nanoscience and Nanotechnology, NCSR "Demokritos", 15310 Aghia Paraskevi, Attikis, Greece;

    Radiochemical/Radiopharmacological Quality Control Laboratory, Institute of Nuclear and Radiological Sciences and Technology, Energy & Safety, N.C.S.R. 'Demokritos', 15310 Aghia Paraskevi, Greece,Department of Medical Instruments Technology, Technological Educational Institute, GR 12210 Athens, Greece;

    Department of Medical Instruments Technology, Technological Educational Institute, GR 12210 Athens, Greece;

    Division of Pharmacology, Clinical, Experimental Surgery, & Translational Research, Biomedical Research Foundation Academy of Athens (BRFAA), Athens 11527, Greece;

    Clinical, Experimental Surgery, & Translational Research, Biomedical Research Foundation Academy of Athens (BRFAA), Athens 11527, Greece;

    Radiochemical/Radiopharmacological Quality Control Laboratory, Institute of Nuclear and Radiological Sciences and Technology, Energy & Safety, N.C.S.R. 'Demokritos', 15310 Aghia Paraskevi, Greece,Department of Medical Instruments Technology, Technological Educational Institute, GR 12210 Athens, Greece;

    Division of Pharmacology, Clinical, Experimental Surgery, & Translational Research, Biomedical Research Foundation Academy of Athens (BRFAA), Athens 11527, Greece;

    Clinical, Experimental Surgery, & Translational Research, Biomedical Research Foundation Academy of Athens (BRFAA), Athens 11527, Greece;

    Institute for Nanoscience and Nanotechnology, NCSR "Demokritos", 15310 Aghia Paraskevi, Attikis, Greece;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号